VACCINE EFFECTIVENESS AGAINST INFECTIONS TRIGGERING AUTOIMMUNE DISEASE
Dr Deborah Burnett,
Scientia Senior Lecturer & Laboratory Head
UNSW Sydney, Australia
RESEARCHER PROFILE
Filmed in Sydney, Australia | April 2026
Dr Deborah Burnett is a Scientia Senior Lecturer and Laboratory Head at UNSW, where she leads a multidisciplinary research program spanning mechanistic immunology and translational vaccinology. Her work focuses on understanding how immune responses can protect against challenging infectious threats, including bacterial infections and infections associated with autoimmune disease.
After completing her PhD in 2019, Dr Burnett established her first independent group at the Garvan Institute in 2022 and launched her laboratory at UNSW in 2024. Her research, published in major research journals including Science and Immunity, has helped redefine how self-reactive B cells contribute to protective immunity and is now shaping new approaches to prevention and cure of infections linked to autoimmunity.
Her contributions to research leadership and translation have been recognised through the NSW Premier’s Prize for Early Career Researcher of the Year, Research Australia’s Discovery Award, the Australian L’Oréal-UNESCO For Women in Science Fellowship, a Young Tall Poppy Award, the Marie Krogh Prize for Women in Science, and selection as an International Union of Immunological Societies Rising Star. Through the Snow Fellowship, Dr Burnett and her team aim to develop new ways to distinguish protective from harmful immune responses, advancing safer vaccines, diagnostics and therapies for vulnerable communities affected by infection-associated autoimmune disease.
Source: Supplied
https://orcid.org/0000-0002-5642-3315
-
Genetic alterations in prostate cancer initiation and progression
Watch Dr Kelsie Raspin, a dedicated Postdoctoral Research Fellow specialising in Cancer Genetics at Menzies Institute for Medical Research, University of Tasmania, talk on bridging a critical knowledge gap in the understanding of genetic alterations implicated in prostate cancer initiation and its progression into metastatic forms.
-
Trials in treating STIs, vaccines and lipid lowering medications
Since joining Paratus Clinical Research in 2022, Dr Pi Lip Seet has served as both Principal Investigator and Sub-Investigator across Phase I–IV industry-sponsored clinical trials. His research experience spans vaccines, immunology, cardiovascular and endocrine disease, respiratory medicine, gastroenterology, pain management, sleep medicine and adult psychiatry. He has been involved in multiple vaccine development programs, including RSV, influenza, COVID-19, herpes zoster and pneumococcal studies.
-
Behavioural science in cancer screening, control and communication
Dr Dodd has an established international reputation as a behavioural scientist in cancer control and communication. Since completing her PhD in 2016, Dr Dodd has been awarded a three-year University of Sydney Postdoctoral Research Fellowship (2018-2021) and a three-year Research Fellowship at The Daffodil Centre (current). Dr Dodd is the co-chair of the ‘Strengthening and optimising approaches to cancer prevention, screening, and early detection’ hub at The Daffodil Centre (with more than 130 staff and students).
